CAMBRIDGE, Mass., June 16, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the underwritten public offering of 3,250,000 shares of its common stock by the Company and 1,000,000 shares of its common stock by certain pre-IPO stockholders of the Company. In addition, the Company and the selling stockholders have granted the underwriters the option to purchase up to 637,500 additional shares to cover over-allotments.
